Abstract
Methadone use for pain relief has surged over the past two decades. In this time, its special pharmacology has been elucidated which has led to speculation about special properties as well as far greater risks than with other opioid medications. Recently, increasing reports of methadone-related unintended deaths have spurred greater concern about this unique drug. Methadone has many advantages that are now well opposed by many posing serious risks for patients in pain. Advantages include cost, ease of use, and multiple opioid and non-opioid receptor actions. However, risks include metabolic instability related to unique P450 system hepatic clearance that poses drug-drug interactions that differ from other opioids, high protein binding, variable urine clearance, and the potential for cardiac arrhythmia. Thus, this drug that saw a renaissance over the past two decades has now been revealed as more dangerous than previously thought and widely noted to require heightened knowledge and risk management for safe use.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Fredheim OM, Moksnes K, Borchgrevink PC, Kaasa S, Dale O. Clinical pharmacology of methadone for pain. Acta Anaesthesiol Scand. 2008;52(7):879–89.
Burns L, Conroy E, Mattick RP. Infant mortality among women on a methadone program during pregnancy. Drug Alcohol Rev. 2010;29(5):551–6.
Broussard CS, Rasmussen SA, Reefhuis J, et al. Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol. 2011;204(4):314.e1–11.
Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: novel clinical applications with related concerns. Pain Med. 2002;3(4):339–48.
George S, Moreira K, Fapohunda M. Methadone and the heart: what the clinician needs to know. Curr Drug Abuse Rev. 2008;1(3):297–302.
Gagajewski A, Apple FS. Methadone-related deaths in Hennepin county, Minnesota: 1992–2002. J Forensic Sci. 2003;48(3):668–71.
Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. QTc interval screening in methadone treatment. Ann Intern Med. 2009;150(6):387–95.
Paulozzi LJ, Ryan GW. Opioid analgesics and rates of fatal drug poisoning in the United States. Am J Prev Med. 2006;31(6):506–11.
Mercadante S, Porzio G, Ferrera P, et al. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain. 2008;12(8):1040–6.
Weschules DJ, Bain KT. A systematic review of opioid conversion ratios used with methadone for the treatment of pain. Pain Med. 2008;9(5):595–612.
Center for Disease Control & Prevention Prescription Painkiller Overdoses: Methadone. 2012. http://www.cdc.gov/Features/VitalSigns/MethadoneOverdoses/index.html
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 American Academy of Pain Medicine
About this chapter
Cite this chapter
Singh, N., Fishman, S.M., Tokarz, K. (2013). Methadone for Chronic Pain. In: Deer, T., et al. Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1560-2_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1560-2_14
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1559-6
Online ISBN: 978-1-4614-1560-2
eBook Packages: MedicineMedicine (R0)